Viewing Study NCT03272152



Ignite Creation Date: 2024-05-06 @ 10:30 AM
Last Modification Date: 2024-10-26 @ 12:31 PM
Study NCT ID: NCT03272152
Status: UNKNOWN
Last Update Posted: 2017-09-05
First Post: 2017-08-31

Brief Title: Comprehensive DNA Methylation Profiling in Crohns Disease
Sponsor: Jinling Hospital China
Organization: Jinling Hospital China

Study Overview

Official Title: Comprehensive DNA Methylation Profiling of Inflammatory and Non-Inflammatory Mucosa in Crohns Disease
Status: UNKNOWN
Status Verified Date: 2017-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Previous studies have indicated that abnormal DNA methylation frequently occurs in the mucosa in Crohns disease Comprehensive DNA methylation profiling of the inflamed and non-inflamed ileal mucosa of patients with Crohns disease was performed Genome-wide DNA methylation was determined using the Illumina HumanMethylation 850k BeadChip
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None